Abstract：
The SFE-AFCE-SFMN 2022 consensus deals with the management of thyroid nodules, a condition that is a frequent reason for consultation in endocrinology. In more than 90% of cases, patients are euthyroid, with benign non-progressive nodules that do not warrant specific treatment. The clinician\'s objective is to detect malignant thyroid nodules at risk of recurrence and death, toxic nodules responsible for hyperthyroidism or compressive nodules warranting treatment. The diagnosis and treatment of thyroid nodules requires close collaboration between endocrinologists, nuclear medicine physicians and surgeons, but also involves other specialists. Therefore, this consensus statement was established jointly by 3 societies: the French Society of Endocrinology (SFE), French Association of Endocrine Surgery (AFCE) and French Society of Nuclear Medicine (SFMN); the various working groups included experts from other specialties (pathologists, radiologists, pediatricians, biologists, etc.). The present section deals with the epidemiology and specificities of diagnosis and treatment of thyroid nodules in pregnant women.
摘要：
SFE-AFCE-SFMN2022共识涉及甲状腺结节的管理，这是内分泌学咨询的常见原因。在90%以上的案例中，患者甲状腺功能正常，良性非进展性结节，不需要特殊治疗。临床医生的目标是检测有复发和死亡风险的恶性甲状腺结节，导致甲状腺功能亢进的毒性结节或压缩性结节需要治疗。甲状腺结节的诊断和治疗需要内分泌学家之间的密切合作,核医学医师和外科医生，但也涉及其他专家。因此,这一共识声明是由3个学会共同建立的：法国内分泌学学会（SFE），法国内分泌外科协会（AFCE）和法国核医学学会（SFMN）；各个工作组包括来自其他专业的专家（病理学家，放射科医生,儿科医生,生物学家,等。).本节涉及孕妇甲状腺结节的流行病学和诊断和治疗的特殊性。
